US 8716473
Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase
granted A61PA61P35/00A61P43/00
Quick answer
US patent 8716473 (Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase) held by SENTINEL ONCOLOGY LIMITED expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEL ONCOLOGY LIMITED
- Grant date
- Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P35/00, A61P43/00